Search

everythinglearnresearchcommunity

for

Search:↓

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Spironolactone plus finasteride reduces hirsutism more effectively.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.